AI Breaks Barriers in Cancer Drug Discovery: Insilico Medicine & U of T Lead with AI-Made Molecules

Insilico Medicine and University of Toronto collaborate to target "undruggable" cancer genes using AI-designed molecules. AI is revolutionizing drug discovery by tackling challenges in targeting difficult areas. Insilico Medicine's Pharma AI suite covers the entire drug development process, making it more efficient and cost-effective. AI's capacity to imagine new molecular structures is addressing the challenge of undruggability. This positive news highlights the potential of AI in improving the success rate of drug discovery.